Disappointing delay for Gensia

Disappointing delay for Gensia

Gensia Inc. on Friday said that it had run into a snag in the initial scale-up of its formulation of Geomatrix nifedipine, and that further formulation will be required.

As

Read the full 342 word article

How to gain access

Continue reading with a
two-week free trial.